Study Advances Knowledge Base About Children and Adolescents With Myeloproliferative Neoplasms
The researchers uncovered higher-than-anticipated rates of thrombosis, hemorrhage, and transformation in their real-world cohort of MPN patients.
Diagnosis & Disease Information
Mobile Exercise App Feasible During Outpatient Chemotherapy for Myeloid Neoplasms
Pilot trial sought to determine the efficacy of using GO-EXCAP, a mobile application, to improve exercise frequency and duration in older patients receiving chemotherapy for myeloid neoplasms.
Cancer Guidelines May Ease Disease-Specific Fatigue in Patients With Myeloproliferative Neoplasm
A qualitative study sought to define the symptoms patients with MPN-related fatigue experience.
Momelotinib Bests Danazol in Symptomatic, Anemic Myelofibrosis
Momelotinib proved superior to danazol in patients with symptomatic, anemic myelofibrosis in a phase 3 study.
The Effect of Gender Bias in Surveys of Patients With Myeloproliferative Neoplasm
Gender balance in cancer surveys was found to have relatively little effect on survey outcomes, according to results of a study presented at the 2022 ASCO Annual Meeting. Surveying patients with myeloproliferative neoplasms (MPN) has given valuable insight into polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) subtypes. However, independent surveys have included a…
LMNB1 Gene Deletion Associated With Change in Nuclear Structure in Myeloid Neoplasms
Researchers sought to determine whether there is a link in loss of LMNB1 expression with changes in myeloid neoplasms.
ROCK1/2 May Be Novel Therapeutic Target in Myeloproliferative Neoplasms
Researchers sought to determine whether inhibiting ROCK1/2 when using interferon therapy would be effective in patients with MPNs.
Longer Azacitidine Schedule Delayed Transformation to Leukemia in Patients With MDS
A head-to-head comparison of 7-day and 5-day treatment schedule of azacitidine in patients with higher risk myelodysplastic syndromes revealed trends in overall survival and time to transformation to leukemia.
Feasibility of Azacitidine in Myelodysplastic/Myeloproliferative Chronic Myelomonocytic Leukemia
A retrospective study sought to determine the response to azacitidine in patients with CMML applying the overlap MDS/MPN response criteria.
Wellness App Aids in Reducing Symptom Burden in Myeloproliferative Neoplasms
Researchers sought to determine the feasibility of a wellness app in reducing symptom burden for patients with myeloproliferative neoplasms.
- Loading...
Loading...
Next post in Myeloproliferative Neoplasms
Loading... 
Loading...